Showing results (91-100 of 231) with videos related to

Sort By:
Pageof 24
Human Pathology|September 25, 2016
Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p lossLorena Lazo de la Vega, Daniel H Hovelson, Andi K Cani, et al.
Cancer Research|January 4, 2008
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancerBeth E Helgeson, Scott A Tomlins, Nameeta Shah, et al.
Neoplasia (New York, N.Y.)|February 20, 2008
Role of the TMPRSS2-ERG gene fusion in prostate cancerScott A Tomlins, Bharathi Laxman, Sooryanarayana Varambally, et al.
Cancer Research|January 31, 2012
PARP-1 inhibition as a targeted strategy to treat Ewing's sarcomaJ Chad Brenner, Felix Y Feng, Sumin Han, et al.
Medical Oncology (Northwood, London, England)|October 7, 2018
Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancerRohit Mehra, Simpa S Salami, Robert Lonigro, et al.
Cancer Research|April 23, 2009
Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancerRou Wang, David S Morris, Scott A Tomlins, et al.
Cancer Research|April 6, 2006
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancerScott A Tomlins, Rohit Mehra, Daniel R Rhodes, et al.
European Urology|August 19, 2018
Managing Nonmetastatic Castration-resistant Prostate CancerJoaquin Mateo, Karim Fizazi, Silke Gillessen, et al.
JAMA Oncology|June 16, 2022
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical TrialNeal D Shore, Joseph Renzulli, Neil E Fleshner, et al.
Cancer Research|November 17, 2007
A polycomb repression signature in metastatic prostate cancer predicts cancer outcomeJindan Yu, Jianjun Yu, Daniel R Rhodes, et al.
Pageof 24